ESPN college football analyst Booger McFarland had some harsh words for Georgia ahead of a key upcoming showdown with rival ...

Fantasy football rankings from Matt Bowen, Mike Clay, Tristan H. Cockcroft, Daniel Dopp, Eric Karabell, Liz Loza, Eric Moody ...

Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...

Participants in the Phase 2a study experienced rapid and meaningful decreases in depressive symptomsSuicidal ideation decreased by 80%SPN-820 was ...

After each team had captured games in the best of three match, IHM took over game three and coasted to victory.

Supernus (SUPN) announced data in a poster presentation at Psych Congress 2024 with new data from its exploratory open-label Phase 2a clinical ...

Ever been caught in the crossfire of a wet dog firing droplets of water away from their fur with a mad shake? Well, they can't help it. Scientists have discovered the underlying mechanism that drives ...

The study examined the safety and tolerability of SPN-820 2400 mg given once every 3 days as an adjunctive treatment to the current baseline antidepressant therapy, as well as assessed the rapid ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ: NASDAQ:SUPN) reported findings from a Phase 2a clinical study of SPN-820, a novel treatment for major depressive disorder (MDD).

Entrepreneurship is one way to spur economic mobility and growth in disinvested communities in both urban and rural areas.

There’s little doubt that some of the most important pillars of modern cryptography will tumble spectacularly once quantum computing, now in its infancy, matures sufficiently. Some experts say that ...

(RTTNews) - Supernus Pharmaceuticals Inc. (SUPN) announced a promising data from its exploratory open-label Phase 2a clinical study of SPN-820 in adults with major depressive disorder. The study ...